Ticagrelor or Clopidogrel to reduce ischemic events after Percutaneous Coronary Intervention in chronic coronary syndrome in clopidogrel naive patient: the ALPHEUS Naive sub-study.

26 August 2023 (10:15 - 10:24)
Organised by: Logo
Congress Presentation Part of: Optimal antithrombotic regimen after percutaneous coronary intervention in stable coronary artery disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology